For subscribers
Getting the formula right in growing local biomedical sector
Sign up now: Get ST's newsletters delivered to your inbox
A biotechnologist overseeing the fermentation process, which is key in vaccine manufacturing, at GlaxoSmithKline Biologicals' manufacturing facility in Tuas.
PHOTO: GLAXOSMITHKLINE
SINGAPORE - Local diagnostics start-up BioCheetah is developing kits to help healthcare professionals quickly identify patients at high risk of having bladder cancer.
Besides a kit that will speed up the diagnosis process in hospitals, it is also looking to roll out a point-of-care test for places that do not have the necessary testing equipment, such as general practitioners' clinics.
